ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
175 hedge funds and large institutions have $1.42B invested in Acorda Therapeutics in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 53 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
34% less call options, than puts
Call options by funds: $18.7M | Put options by funds: $28.5M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
175
Holding in Top 10
1
Calls
$18.7M
Puts
$28.5M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$13.6M | |
| 3 | +$12.9M | |
| 4 |
BlackRock
New York
|
+$11.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$5.62M |
Top Sellers
| 1 | -$34.3M | |
| 2 | -$31.1M | |
| 3 | -$24.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$18.3M |
| 5 |
HM
HealthCor Management
New York
|
-$18.2M |